272. Fibrodysplasia ossificans progressiva Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 55 / Drugs : 51 - (DrugBank : 9) / Drug target genes : 28 - Drug target pathways : 106
Fibrodysplasia ossificans progressiva and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 272 | Fibrodysplasia ossificans progressiva | - |
| 6 | Parkinson disease | 19.011 |
| 140 | Dorabe syndrome | 17.308 |
| 13 | Multiple sclerosis/Neuromyelitis optica | 17.280 |
| 144 | Lennox-Gastaut syndrome | 17.268 |
| 193 | Prader-Willi syndrome | 17.195 |
| 298 | Hereditary pancreatitis | 17.126 |
| 70 | Spinal stenosis | 16.783 |
| 156 | Rett syndrome | 16.583 |
| 97 | Ulcerative colitis | 16.030 |
| 152 | PCDH19-related syndrome | 16.000 |
| 96 | Crohn disease | 15.934 |
| 201 | Angelman syndrome | 14.322 |
| 205 | Fragile X syndrome related disease | 13.785 |
| 145 | West syndrome | 13.493 |
| 22 | Moyamoya disease | 13.363 |
| 155 | Acquired aphasia with convulsive disorder | 13.241 |
| 2 | Amyotrophic lateral sclerosis | 13.041 |
| 231 | Alpha-1-antitrypsin deficiency | 12.659 |
| 158 | Tuberous sclerosis | 12.659 |
| 8 | Huntington disease | 12.306 |
| 34 | Neurofibromatosis | 12.265 |
| 98 | Eosinophilic gastro-intestinal disorder | 12.248 |
| 296 | Biliary atresia | 12.034 |
| 18 | Spinocerebellar degeneration | 12.034 |
| 21 | Mitochondrial disease | 11.941 |
| 36 | Epidermolysis bullosa | 11.856 |
| 3 | Spinal muscular atrophy | 11.704 |
| 206 | Fragile X syndrome | 11.670 |
| 46 | Malignant rheumatoid arthritis | 11.656 |
| 17 | Multiple system atrophy | 11.460 |
| 75 | Cushing disease | 11.434 |
| 5 | Progressive supranuclear palsy | 11.361 |
| 84 | Sarcoidosis | 11.047 |
| 58 | Hypertrophic cardiomyopathy | 3.385 |
| 67 | Polycystic kidney disease | 2.113 |
| 167 | Marfan syndrome | 1.969 |
| 81 | Congenital adrenal hyperplasia | 1.744 |
| 51 | Scleroderma | 1.630 |
| 86 | Pulmonary arterial hypertension | 1.163 |